Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-Hodgkin Lymphoma · Cytokine Release Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Taylor Brooks, MD) · TaussigResearch@ccf.org · 866-223-8100
Study leads
  • Taylor Brooks, MD

    Principal Investigator

    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center